Anbio Biotechnology (NNNN)
Recent Filing Index
Filing Summary
| Report Name | Notes | Fiscal Period (Annual) | Fiscal Period (Quarter) |
|---|---|---|
| Cover | — |
|
| Audit Information | — |
|
| Statements | ||
| Consolidated Balance Sheets | — |
|
| Consolidated Balance Sheets (P) | — |
|
| Consolidated Statements of Operations | — |
|
| Consolidated Statements of Changes In Shareholders Equity | — |
|
| Consolidated Statements of Cash Flows | — |
|
| Consolidated Statements of Cash Flows (P) | — |
|
| Notes | ||
| Accounts Receivable, Net | — |
|
| Certain Risks and Concentration | — |
|
| Commitments and Contingencies | — |
|
| Cybersecurity Risk Management and Strategy Disclosure | — |
|
| Earnings Per Share | — |
|
| Insider Trading Policies and Procedures | — |
|
| Nature of Business and Organization | — |
|
| Other Current Liabilities | — |
|
| Pay Vs Performance Disclosure | — |
|
| Prepaid and Other Current Assets | — |
|
| Shareholders Equity | — |
|
| Short-term Investment | — |
|
| Stockholder's Equity | — |
|
| Subsequent Events | — |
|
| Summary of Significant Accounting Policies | — |
|